Strategic Blueprint’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $571K | Buy |
12,341
+92
| +0.8% | +$4.26K | 0.03% | 421 |
|
|
2025
Q1 | $747K | Sell |
12,249
-435
| -3% | -$26.5K | 0.04% | 342 |
|
|
2024
Q4 | $717K | Buy |
12,684
+502
| +4% | +$28.4K | 0.04% | 325 |
|
|
2024
Q3 | $630K | Sell |
12,182
-4,314
| -26% | -$223K | 0.04% | 351 |
|
|
2024
Q2 | $685K | Sell |
16,496
-797
| -5% | -$33.1K | 0.05% | 307 |
|
|
2024
Q1 | $938K | Buy |
17,293
+7,578
| +78% | +$411K | 0.07% | 252 |
|
|
2023
Q4 | $498K | Buy |
9,715
+4,275
| +79% | +$219K | 0.04% | 353 |
|
|
2023
Q3 | $316K | Buy |
5,440
+431
| +9% | +$25K | 0.03% | 404 |
|
|
2023
Q2 | $320K | Buy |
5,009
+158
| +3% | +$10.1K | 0.03% | 406 |
|
|
2023
Q1 | $336K | Buy |
4,851
+563
| +13% | +$39K | 0.03% | 375 |
|
|
2022
Q4 | $309K | Buy |
4,288
+693
| +19% | +$49.9K | 0.04% | 391 |
|
|
2022
Q3 | $256K | Buy |
3,595
+149
| +4% | +$10.6K | 0.03% | 409 |
|
|
2022
Q2 | $265K | Sell |
3,446
-995
| -22% | -$76.5K | 0.03% | 397 |
|
|
2022
Q1 | $324K | Sell |
4,441
-13
| -0.3% | -$948 | 0.04% | 371 |
|
|
2021
Q4 | $278K | Sell |
4,454
-2,896
| -39% | -$181K | 0.04% | 395 |
|
|
2021
Q3 | $435K | Buy |
7,350
+3,076
| +72% | +$182K | 0.07% | 257 |
|
|
2021
Q2 | $286K | Buy |
+4,274
| New | +$286K | 0.04% | 304 |
|
|
2019
Q4 | – | Sell |
-89
| Closed | -$5K | – | 130 |
|
|
2019
Q3 | $5K | Buy |
+89
| New | +$5K | ﹤0.01% | 353 |
|